Explore Prostate Cancer Treatment and Care, including robotic surgery, hormone therapy, rehabilitation, and personalized treatment plans at LIV Hospital.
Send us all your questions or requests, and our expert team will assist you.
The Treatment Details for prostate cancer at Liv Hospital are designed to give international patients a clear, step‑by‑step understanding of every therapeutic option available. Whether you are newly diagnosed or seeking a second opinion, this guide explains the full spectrum of care—from minimally invasive surgery to advanced systemic therapies—so you can make informed decisions in partnership with our multidisciplinary team.
Prostate cancer is the second most common cancer among men worldwide, affecting approximately 1 in 8 men over the age of 50. Early detection and personalized treatment plans dramatically improve long‑term survival and quality of life. At Liv Hospital, our JCI‑accredited facilities combine cutting‑edge technology with compassionate, 360‑degree international patient support, ensuring that every aspect of your journey is coordinated, comfortable, and evidence‑based.
In the sections that follow, you will find detailed explanations of each treatment modality, the typical sequence of care, potential side effects, and the supportive services we provide to help you navigate travel, accommodation, and language barriers. Our aim is to empower you with the knowledge you need to choose the right path forward.
Prostate cancer treatment is highly individualized, based on tumor stage, Gleason score, PSA level, patient age, overall health, and personal preferences. The main categories of therapy include:
Each option has distinct goals—curative intent for localized disease, disease control for advanced stages, and symptom management for metastatic cases. The following table summarizes key characteristics of the primary modalities:
Understanding these treatment details helps patients and families weigh the trade‑offs between efficacy, side‑effect profiles, and lifestyle considerations. At Liv Hospital, our specialists review all data with you before finalizing a personalized plan.
Surgery remains a cornerstone for curative treatment of localized prostate cancer. The two most common procedures are open radical prostatectomy and robot‑assisted laparoscopic prostatectomy, both performed by board‑certified urologic oncologists.
This minimally invasive technique uses a Da Vinci® surgical system to provide high‑definition 3‑D visualization and precise instrument control. Benefits include reduced blood loss, shorter hospital stay (typically 1–2 days), and faster return to normal activities.
Open surgery may be preferred for very large prostates or when previous abdominal surgeries have created adhesions. While the incision is larger, outcomes in terms of cancer control are comparable when performed by experienced surgeons.
Key steps in the surgical pathway are outlined below:
Potential complications include urinary incontinence, erectile dysfunction, and rare events such as deep vein thrombosis. Liv Hospital’s rehabilitation team offers pelvic floor physiotherapy and sexual health counseling to mitigate these effects.
When prostate cancer advances beyond the prostate gland, systemic treatments become essential. These therapies target cancer cells throughout the body and are often combined with local treatments for a multimodal approach.
ADT reduces circulating testosterone, which fuels prostate cancer growth. Options include luteinizing hormone‑releasing hormone (LHRH) agonists, antagonists, and surgical castration (orchiectomy). ADT is frequently used alongside radiation for high‑risk localized disease and as a backbone for metastatic management.
Docetaxel, administered intravenously every three weeks, has been the standard first‑line chemotherapy for metastatic castration‑resistant prostate cancer (mCRPC). Recent trials have added cabazitaxel and platinum‑based regimens for patients progressing after docetaxel.
Emerging treatments such as pembrolizumab (PD‑1 inhibitor) and PARP inhibitors (olaparib, rucaparib) are approved for selected patients with specific genetic alterations (e.g., MSI‑H, BRCA mutations). These agents offer a personalized approach, extending survival for a subset of men with advanced disease.
Below is a concise list of systemic options and typical usage scenarios:
Liv Hospital’s oncology pharmacists and genetic counselors work together to identify eligible patients for targeted therapies, ensuring that the most appropriate treatment details are applied based on molecular profiling.
Radiation therapy provides a non‑surgical curative option for patients who wish to avoid surgery or for whom surgery is contraindicated. Modern techniques have dramatically improved precision, reducing exposure to surrounding healthy tissue.
EBRT delivers high‑energy X‑rays from a linear accelerator. Intensity‑modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) allow dose painting that conforms to the prostate shape while sparing the rectum and bladder.
Low‑dose‑rate (LDR) brachytherapy involves permanent implantation of radioactive seeds (typically I‑125) directly into the prostate. This method is ideal for low‑ to intermediate‑risk disease and offers a shorter treatment course.
SBRT delivers ablative doses in 5‑7 fractions, combining the convenience of a hypofractionated schedule with the precision of image‑guided radiotherapy. Clinical trials have shown comparable biochemical control to conventional EBRT.
Radiation side effects are generally mild and include urinary frequency, rectal irritation, and temporary fatigue. A typical schedule is illustrated below:
Liv Hospital’s radiation oncology team utilizes state‑of‑the‑art imaging and motion‑management systems to ensure that each dose is delivered exactly where it is needed, maximizing tumor control while preserving quality of life.
Effective prostate cancer management relies on coordinated care across specialties. At Liv Hospital, a dedicated tumor board convenes weekly to review each case, integrating insights from urology, radiation oncology, medical oncology, pathology, radiology, and supportive care services.
Follow‑up protocols are tailored to disease stage and treatment modality. For example, after radical prostatectomy, PSA is measured at 6 weeks, then every 3 months for the first year. After radiation, PSA testing begins at 3 months and continues semi‑annually.
The integrated approach ensures that any biochemical recurrence or treatment‑related complication is detected early, allowing timely intervention. Liv Hospital’s patient navigation team assists international patients in scheduling follow‑up appointments, arranging tele‑medicine consultations, and coordinating travel back to Istanbul when needed.
Undergoing prostate cancer therapy far from home can be daunting. Liv Hospital’s 360‑degree international patient program is designed to streamline every logistical and emotional aspect of your journey.
Before your first visit, you will receive a detailed welcome packet containing:
By handling these details ahead of time, Liv Hospital allows you to focus on recovery and treatment outcomes rather than administrative hurdles.
Liv Hospital combines JCI accreditation, cutting‑edge technology, and a truly international patient framework. Our multidisciplinary teams are experienced in treating prostate cancer across all stages, and our dedicated concierge service ensures seamless coordination of medical and travel logistics. With a reputation for high success rates and patient‑centered care, Liv Hospital is a trusted partner for those seeking world‑class oncology treatment away from home.
Ready to discuss your prostate cancer treatment plan with our experts? Contact Liv Hospital today to schedule a personalized consultation and take the first step toward confident, comprehensive care.
Send us all your questions or requests, and our expert team will assist you.
Prostate cancer treatment is individualized based on stage, Gleason score, PSA level, age, and patient preferences. Active surveillance is used for low‑risk disease to avoid overtreatment. Surgical options range from open radical prostatectomy to robot‑assisted laparoscopic prostatectomy, offering curative intent for localized tumors. Radiation therapy can be delivered as external beam (IMRT/VMAT), brachytherapy, or stereotactic body radiotherapy, each with specific dosing schedules. Systemic therapies become essential for advanced or metastatic disease and include androgen deprivation therapy (ADT), chemotherapy agents like docetaxel, and newer immunotherapies or PARP inhibitors for selected genetic profiles.
Robot‑assisted laparoscopic prostatectomy employs a 3‑D high‑definition camera and articulated instruments that allow precise dissection through several small incisions. Benefits include reduced intra‑operative blood loss, shorter hospital stay (typically 1–2 days), and quicker return to daily activities. Open radical prostatectomy requires a larger lower‑abdominal incision, which may be preferred for very large glands or when prior abdominal surgeries have caused adhesions. While oncologic outcomes are comparable when performed by experienced surgeons, the open approach generally involves longer recovery and higher postoperative pain.
Androgen deprivation therapy reduces circulating testosterone, slowing tumor growth. However, the hormonal shift leads to vasomotor symptoms like hot flashes, decreased bone mineral density increasing fracture risk, and changes in body composition (increased fat, reduced muscle mass). Patients may also experience reduced libido, erectile dysfunction, fatigue, and metabolic alterations that raise the risk of diabetes and cardiovascular disease. Regular monitoring of bone health, cardiovascular risk factors, and supportive measures such as exercise, calcium/vitamin D supplementation, and lifestyle counseling are recommended.
Radiation therapy dosing varies by technique. Intensity‑modulated radiation therapy (IMRT) or volumetric modulated arc therapy (VMAT) deliver daily fractions (usually 2 Gy) across 38–44 sessions, spanning roughly 7–8 weeks. Low‑dose‑rate (LDR) brachytherapy involves implanting radioactive seeds in a single outpatient visit, with the radiation emitted continuously over weeks to months. Stereotactic body radiotherapy (SBRT) delivers high‑dose, ablative fractions in 5–7 treatments, completing the course within 1–2 weeks, offering convenience while maintaining comparable biochemical control to conventional schedules.
International patients receive comprehensive assistance from Liv Hospital’s patient navigation team. Services include arranging airport transfers, visa documentation, and hotel bookings near the hospital. Professional medical interpreters facilitate communication during consultations and treatment. The hospital also provides a 360‑degree support system covering pre‑operative assessments, post‑operative rehabilitation (pelvic floor physiotherapy, sexual health counseling), and survivorship programs. Follow‑up appointments can be scheduled locally or via tele‑medicine, and travel back to Istanbul for further care is coordinated as needed.
BlogCancerFeb 19, 2026We often hear about cancer being diagnosed at various stages. Stage zero is the earliest, non-invasive stag...
BlogCancerFeb 19, 2026Prostate cancer is a big worry for men. The American Cancer Society says there will be 313,780 new cases an...
BlogCancerFeb 19, 2026Prostate cancer is a big health worry for men all over the world. It’s the second most common cancer ...
BlogCancerFeb 19, 2026Prostate cancer is a big worry for men all over the world. But, the good news is that it can often be cured...
BlogCancerFeb 19, 2026Prostate cancer is a significant concern for men, particularly in the U.S., where it constitutes a major po...
BlogCancerFeb 19, 2026Men worried about prostate health or dealing with Benign Prostatic Hyperplasia (BPH) should know some drink...
